These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase. Barlaam B; Ballard P; Bradbury RH; Ducray R; Germain H; Hickinson DM; Hudson K; Kettle JG; Klinowska T; Magnien F; Ogilvie DJ; Olivier A; Pearson SE; Scott JS; Suleman A; Trigwell CB; Vautier M; Whittaker RD; Wood R Bioorg Med Chem Lett; 2008 Jan; 18(2):674-8. PubMed ID: 18061446 [TBL] [Abstract][Full Text] [Related]
48. Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families. Curtin ML; Frey RR; Heyman HR; Soni NB; Marcotte PA; Pease LJ; Glaser KB; Magoc TJ; Tapang P; Albert DH; Osterling DJ; Olson AM; Bouska JJ; Guan Z; Preusser LC; Polakowski JS; Stewart KD; Tse C; Davidsen SK; Michaelides MR Bioorg Med Chem Lett; 2012 May; 22(9):3208-12. PubMed ID: 22465635 [TBL] [Abstract][Full Text] [Related]
49. Design, synthesis and biological evaluation of β-carboline derivatives as novel inhibitors targeting B-Raf kinase. Xin B; Tang W; Wang Y; Lin G; Liu H; Jiao Y; Zhu Y; Yuan H; Chen Y; Lu T Bioorg Med Chem Lett; 2012 Jul; 22(14):4783-6. PubMed ID: 22704238 [TBL] [Abstract][Full Text] [Related]
50. Application of a novel [3+2] cycloaddition reaction to prepare substituted imidazoles and their use in the design of potent DFG-out allosteric B-Raf inhibitors. Dietrich J; Gokhale V; Wang X; Hurley LH; Flynn GA Bioorg Med Chem; 2010 Jan; 18(1):292-304. PubMed ID: 19962319 [TBL] [Abstract][Full Text] [Related]
51. Computer-aided design and synthesis of 3-carbonyl-5-phenyl-1 Kim J; Choi B; Im D; Jung H; Moon H; Aman W; Hah JM J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1314-1320. PubMed ID: 31307243 [TBL] [Abstract][Full Text] [Related]
52. Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas. Li HF; Lu T; Zhu T; Jiang YJ; Rao SS; Hu LY; Xin BT; Chen YD Eur J Med Chem; 2009 Mar; 44(3):1240-9. PubMed ID: 18947905 [TBL] [Abstract][Full Text] [Related]
53. Potent and selective pyrazole-based inhibitors of B-Raf kinase. Hansen JD; Grina J; Newhouse B; Welch M; Topalov G; Littman N; Callejo M; Gloor S; Martinson M; Laird E; Brandhuber BJ; Vigers G; Morales T; Woessner R; Randolph N; Lyssikatos J; Olivero A Bioorg Med Chem Lett; 2008 Aug; 18(16):4692-5. PubMed ID: 18676143 [TBL] [Abstract][Full Text] [Related]
55. Discovery of novel imidazo[1,2-a]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase. Ducray R; Simpson I; Jung FH; Nissink JW; Kenny PW; Fitzek M; Walker GE; Ward LT; Hudson K Bioorg Med Chem Lett; 2011 Aug; 21(16):4698-701. PubMed ID: 21775140 [TBL] [Abstract][Full Text] [Related]
56. Identification of quinazolinyloxy biaryl urea as a new class of SUMO activating enzyme 1 inhibitors. Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY Bioorg Med Chem Lett; 2013 Sep; 23(18):5145-9. PubMed ID: 23920437 [TBL] [Abstract][Full Text] [Related]
58. B-Raf kinase inhibitors: hit enrichment through scaffold hopping. Gopalsamy A; Shi M; Hu Y; Lee F; Feldberg L; Frommer E; Kim S; Collins K; Wojciechowicz D; Mallon R Bioorg Med Chem Lett; 2010 Apr; 20(8):2431-4. PubMed ID: 20307980 [TBL] [Abstract][Full Text] [Related]
59. The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinase. Ren L; Ahrendt KA; Grina J; Laird ER; Buckmelter AJ; Hansen JD; Newhouse B; Moreno D; Wenglowsky S; Dinkel V; Gloor SL; Hastings G; Rana S; Rasor K; Risom T; Sturgis HL; Voegtli WC; Mathieu S Bioorg Med Chem Lett; 2012 May; 22(10):3387-91. PubMed ID: 22534450 [TBL] [Abstract][Full Text] [Related]
60. Bis-aryl urea derivatives as potent and selective LIM kinase (Limk) inhibitors. Yin Y; Zheng K; Eid N; Howard S; Jeong JH; Yi F; Guo J; Park CM; Bibian M; Wu W; Hernandez P; Park H; Wu Y; Luo JL; LoGrasso PV; Feng Y J Med Chem; 2015 Feb; 58(4):1846-61. PubMed ID: 25621531 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]